Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China

Emerg Microbes Infect. 2020 Dec;9(1):1230-1232. doi: 10.1080/22221751.2020.1766383.
No abstract available

Keywords: COVID-19; SARS-CoV-2; clinical character; imported case; prevalence.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Ascorbic Acid / therapeutic use
  • Betacoronavirus / drug effects
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • China / epidemiology
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / physiopathology*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / physiopathology*
  • SARS-CoV-2
  • Severity of Illness Index
  • Thymalfasin / therapeutic use
  • Travel
  • Treatment Outcome

Substances

  • Antibodies, Viral
  • Immunologic Factors
  • Hydroxychloroquine
  • Ascorbic Acid
  • Thymalfasin

Grants and funding

This work was supported by National Natural Science Foundation of China: [grant number 81900005]; Science and Technology Commission of Shanghai Municipality: [grant number 20411950200].